Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Safety and Efficacy of Covid-19 Vaccines Among Patients With Multiple Sclerosis: Letter to Editor Publisher



Mirmosayyeb O1, 2 ; Ghaffary EM1 ; Zabeti A3 ; Shaygannejad V1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department Neurology, University of Cincinnati, Cincinnati, OH, United States

Source: International Journal of Preventive Medicine Published:2024


Abstract

[No abstract available]